Kiniksa Pharmaceuticals Q4 EPS $0.35 Beats $(0.14) Estimate, Sales $83.39M Beat $72.02M Estimate
Author: Happy Mohamed | February 28, 2024 08:31am
Kiniksa Pharmaceuticals (NASDAQ:
KNSA) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $(0.14) by 350 percent. This is a 483.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $83.39 million which beat the analyst consensus estimate of $72.02 million by 15.79 percent. This is a 34.76 percent increase over sales of $61.88 million the same period last year.
Posted In: KNSA